Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-01-30Clinical Trial Update: A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease [Phase 2]
This document reports the completion of a Phase 2 clinical trial evaluating the efficacy of MEDI8968 in chronic obstructive pulmonary diseas…
-
FDA approval · 2017-01-27FDA Approved: FLUTICASONE PROPIONATE AND SALMETEROL — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's Fluticasone Propionate and Salmeterol under an Original Application (NDA208799), a fixed-dose inhaled corticosteroid/lon…
-
FDA approval · 2017-01-27FDA Approved: BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for budesonide and formoterol fumarate dihydrate to update the product labeling for AstraZeneca's in…
-
CLINICAL_TRIALS trial_result · 2017-01-27Clinical Trial Update: The Effects of Broccoli Sprout Extract on Obstructive Lung Disease [NA]
A Johns Hopkins University clinical trial evaluated broccoli sprout extract for obstructive lung diseases (asthma and chronic obstructive pu…
-
EMA withdrawal · 2017-01-26EMA Withdrawn: Vylaer Spiromax (Budesonide;formoterol fumarate dihydrate) — Teva Pharma B.V.
The EMA has withdrawn Vylaer Spiromax (budesonide/formoterol) from the market in the EU.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2017-01-26Clinical Trial Update: Respiratory Muscle Strength and Function in Neuromuscular Disorders and Chronic Obstructive Pulmonary Disease
This clinical trial update reports on respiratory muscle strength and function in patients with neuromuscular disorders and chronic obstruct…
-
CLINICAL_TRIALS trial_result · 2017-01-25Clinical Trial Update: A Phase I Pharmacokinetic Study of Fluticasone Furoate /Umeclidinium Bromide/Vilanterol (100/62.5/25 Microgram [mcg]) After Single and Repeat Dose Administration From a Dry Powder Inhaler in Healthy Chinese Subjects [Phase 1]
Phase I pharmacokinetic study in healthy Chinese subjects evaluating single and repeat doses of the inhaled triple therapy Fluticasone furoa…
-
CLINICAL_TRIALS trial_result · 2017-01-25Clinical Trial Update: Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS) [Phase 4]
Phase 4 trial evaluating roflumilast in COPD patients already treated with fixed-dose LABA/ICS combinations. Results were posted in January …
-
CLINICAL_TRIALS trial_result · 2017-01-20Clinical Trial Update: Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Phase 3 clinical trial update on survival in chronic obstructive pulmonary disease; the study has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-20Clinical Trial Update: SERETIDE 50/500mcg Versus Tiotropium Bromide On Exacerbation Rates In Severe Chronic Obstructive Pulmonary Disease [Phase 4]
Phase 4 trial comparing Seretide (fluticasone propionate/salmeterol) 50/500 mcg with tiotropium in severe COPD; study completed.
-
CLINICAL_TRIALS trial_result · 2017-01-20Clinical Trial Update: Advair® DISKUS® Versus Serevent® DISKUS® For Chronic Obstructive Pulmonary Disease Exacerbations [Phase 4]
A Phase 4 trial comparing Advair Diskus to Serevent Diskus in COPD exacerbations has completed, sponsored by GlaxoSmithKline.
-
CLINICAL_TRIALS trial_result · 2017-01-20Clinical Trial Update: BI 113608 Administered as Tablets Twice Daily Over 4 Weeks in Patients With Chronic Obstructive Pulmonary Disease Associated With Chronic Bronchitis [Phase 1]
A Phase 1 trial evaluated the safety, tolerability, and pharmacokinetics of BI 113608 given as twice-daily tablets for 4 weeks in patients w…
-
CLINICAL_TRIALS trial_result · 2017-01-20Clinical Trial Update: Chronic Obstructive Pulmonary Disease Endpoints Study [Phase 4]
This document reports an update on a Phase 4 COPD endpoints study sponsored by GlaxoSmithKline, noting the trial has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-20Clinical Trial Update: Treatment Of Partial Reversible Chronic Obstructive Pulmonary Disease [Phase 3]
A Phase 3 trial evaluating treatment for partial reversible chronic obstructive pulmonary disease has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Study to Evaluate Safety, Tolerability and Pharmacokinetics of GSK2269557 to Japanese Healthy Subjects [Phase 1]
Phase 1 study evaluating safety, tolerability, and pharmacokinetics of GSK2269557 in Japanese healthy subjects has completed.
-
CLINICAL_TRIALS research · 2017-01-18Clinical Trial Update: Tele-spirometry in Primary Care-Randomized Clinical Trial Cluster:Telemedicine in Chronic Obstructive Pulmonary Disease [NA]
Clinical trial update about a cluster randomized study investigating tele-spirometry and telemedicine for chronic obstructive pulmonary dise…
-
CLINICAL_TRIALS withdrawal · 2017-01-16Clinical Trial Update: A Novel Unidirectional Face Mask During NPPV in COPD Patients [NA]
A clinical trial evaluating a novel unidirectional face mask during noninvasive positive pressure ventilation in COPD patients has been with…
-
CLINICAL_TRIALS trial_result · 2017-01-16Clinical Trial Update: Epidemiology and Pulmonary Response To Organic Dust Exposure
A completed NHLBI trial update examining the epidemiology and pulmonary response to organic dust exposure, with findings relevant to obstruc…
-
CLINICAL_TRIALS trial_result · 2017-01-16Clinical Trial Update: Beetroot Juice - Effects on Performance in Chronic Obstructive Pulmonary Disease Patients [NA]
Completed clinical trial assessing whether beetroot juice improves performance in patients with moderate chronic obstructive pulmonary disea…
-
CLINICAL_TRIALS withdrawal · 2017-01-12Clinical Trial Update: Cardiac Hemodynamics in Overlap Syndrome (COPD With Obstructive Sleep Apnea) [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluating cardiac hemodynamics in overlap syndrome (COPD with obstructive sleep apnea) has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Respiratory Therapy in COPD Exacerbations [NA]
A clinical trial update noting the completion of a study evaluating respiratory therapy for COPD exacerbations. The sponsor was Parc de Salu…
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: Transdiaphragmatic Pressure and Neural Respiratory Drive Measured During Inspiratory Muscle Training in COPD [NA]
This ClinicalTrials.gov entry reports a completed study examining transdiaphragmatic pressure and neural respiratory drive during inspirator…
-
CLINICAL_TRIALS research · 2017-01-11Clinical Trial Update: Platelet Activation and Reactivity in Acute Exacerbations of COPD
Clinical trial update examining platelet activation and reactivity during acute exacerbations of chronic obstructive pulmonary disease.
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: Home-based Treatment of Patients With Chronic Obstructive Pulmonary Disease (COPD) [NA]
A completed clinical trial investigating home-based treatment for chronic obstructive pulmonary disease (COPD).
-
CLINICAL_TRIALS trial_result · 2017-01-06Clinical Trial Update: To Evaluate the Effect of Inhaled Medication Together With Exercise and Activity Training on Exercise Capacity and Daily Activities in Patients With Chronic Lung Disease With Obstruction of Airways [Phase 3]
A Phase 3 trial assessed an inhaled COPD medication combined with exercise and activity training to improve exercise capacity and daily acti…